Skip to content
Disclosery

Propel Bio Management, LLC: AKRO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Propel Bio Management, LLC on AKRO, newest first. How the timeline and the estimate are built.

Propel Bio Management, LLC held 0 AKRO shares at 2025-12-31 per its 13F-HR filed 2026-02-11.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -228,884 shares

    13F-HR 0000898432-26-000087 filed by Propel Bio Management, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 228,884 shares
    Change vs previous 13F 0 shares

    10.88% of the 13F portfolio, value $10,867,412.

    13F-HR 0000898432-25-000886 filed by Propel Bio Management, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 228,884 shares
    Change vs previous 13F 0 shares

    14.82% of the 13F portfolio, value $12,213,250.

    13F-HR 0000898432-25-000591 filed by Propel Bio Management, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 228,884 shares
    Change vs previous 13F -114,845 shares

    10.76% of the 13F portfolio, value $9,265,224.

    13F-HR 0000898432-25-000357 filed by Propel Bio Management, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-12-31
    13F 343,729 shares
    Change vs previous 13F 0 shares

    9.5% of the 13F portfolio, value $9,562,541.

    13F-HR 0001829126-25-000973 filed by Propel Bio Management, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2024-09-30
    13F 343,729 shares
    Change vs previous 13F not available

    5.72% of the 13F portfolio, value $9,861,585.

    13F-HR 0001829126-24-007453 filed by Propel Bio Management, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).